Member Info for Badsterman

1.7 trillion for pharma M&A in 2022.

https://www.fiercepharma.com/pharma/m-a-large-biotech-pharma-companies-will-have-1-7t-firepower-for-dealmaking-2022

Perhaps the Indian distributor isn't paying up for the first shipment of 45,000, therefore NNN are refusing to supply more.

Certainly a well qualified hunch RB, and I heartily endorse the praise for Suzy.

Personally I'm holding out for SNG P3 results and hopefully EUA , then I'll be back here buying more.

I see VAL as a longer term buy and hold. However I could miss out if Suzy pulls a stonking deal out of the bag.

Strategies ehh? :-)

Chunky buy RB, nice one.

What makes you think we'll be "rewarded"?
Rumour?
Hunch?
Level 2 activity?

I'm keeping some powder dry :-)

Ohhh... The irony of a poster failing miserably at spelling and grammar, yet accuses me of being a "thicko".

I would tell you to go back to school, but it's unlikely you ever attended in the first place.

At last!! A marketing strategy.

And they state "the company is experiencing increased awareness"

Give the new CEO a chance!!

A positive update regarding BC201 would be good, especially in the current climate.

Particularly so if follicle regeneration is a side effect. :-)

Poor,

I'm afraid mud sticks and the RMS debacle is still hanging around like a bad smell.

The new CEO can change all that with this gift horse of an opportunity.

Side effects too....urrghh.

"scientists raised some concerns about molnupiravir, including around evidence from animal studies of impaired bone and cartilage growth as well as the potential for birth defects. And because molnupiravir works by introducing a series of errors into a virus' genetic code, FDA scientists questioned whether the drug might trigger unwanted long-term effects or create new coronavirus variants.

Additionally, the available safety data is limited, meaning rare side effects that haven't been detected in testing could occur when the drug is cleared for use in the broader population, FDA reviewers said."

They must be desperate to give that an EUA.

I agree with you about AIM,

But NNN have got form for being slow witted, incompetent and completely lacking in business acumen (I blame Brown, Legge et al) - most savvy investors won't fall for the same failures twice.

The new CEO could be different....

3.5p, you're having a laugh!!

That's a 72 million odd MCAP for a company with minimal sales, in a pandemic!!

The first step has got to be a marketing strategy, starting Monday morning.

Banner ads, clickbait, paid articles, twitter hashtags, instagram and tik tok clips - (not an exhaustive list).

Spend a couple of million and get the word out there.

Make some sales and we might have a chance of 2p.

I know it's not all about masks, but this is a tremendous opportunity.

Over to you NNN.

Well Rare Groove, this is a golden opportunity for the new CEO to make his mark.

It's a second chance for NNN, if they can't deliver a marketing campaign and mask/filter sales in this environment then I'm out.

(I've just ordered 50 from Numed to get 'em started!)

The omicron variant was found in Nottingham, I wonder if they have a supplier of masks to help protect the local populace?

Terrible news, but what a tremendous opportunity for NNN - have they got the business nous to grab it?

Thanks for the reply Rhubarb,

Toxicology analysis is due shortly, coupled with details of SRA737 combos going into clinic.

Anyway, enough from me about SAR ;~)

Rhubarb,

Excellent post comparing SAR and VAL,

As someone invested in both companies (and an avid reader of the respective chat boards), I was interested to note your comment "there are others in development, and quite targeted variations too",

Can you be more specific about the competition? The SAR board believe they have the only TYK2/JAK1 inhibitor with no tox issues (albeit pre-clinical).

Personally I'm hedging my bets across SAR, VAL and SNG, to try and guarantee at least one big winner!

Regards

Well,

I managed a modest top-up, although it took 15 minutes to execute the trade.

Gotta a good feeling about tomorrow - come on Soooooozy!!

"extremely poor in keeping market updated"

Last week Sareum ran an investor presentation - to keep the market updated!!

FFS!! What more do you want!!

Yep, inflation is up yet RM staff got 1% this year.
The USO is failing left, right and centre yet RMG are paying a special dividend and share buybacks?
Neither OFCOM or the CWU are gonna be pleased with this scenario.
A storm is coming.

One big name contract for Microsalt and we're off to poundland.

Oh...and Belluscura are going great guns, Lucyd about to float, news from Guident could hit anytime and we might be on boarding some new tech soon.

Most microcap shares have one or two USP's, TEK have FOUR with multiple patents and one already listed on AIM.

Love this share.

Come on Valtree, you stand accused of being an illiterate, inept charlatan.

I'm seriously interested in your defence, or is the "lifeboat" gag the best you've got?